Abstract Submission
DEADLINE: THURSDAY 26 June 2025 at 23:59 CET
The Organizing Committee welcomes the submission of abstracts for Posters, Flash Talks and Oral Presentations for PAAM 2025.
- Please note that abstracts received after the deadline will not be considered.
- Please note that there will NOT be a Late Breaking Abstract submission.
- Abstracts will be presented only on-site in Palma. No online presentation will be accepted.
General abstract information
- Original laboratory research, clinical research and case presentations are equally welcome.
- Presentation Formats:
- Oral Presentation (OAS)
- Flash Talk (FT)
- Poster (TPS)
Oral Presentation (OAS)
The Oral Presentations will be featured onsite in Palma during the dedicated PAAM Sessions. As presenter you are required to prepare a MS PowerPoint presentation featuring the main findings of your work.
Flash Talk (FT)
The Flash Talks will be featured onsite in Palma during the dedicated PAAM Sessions. As presenter you have the opportunity to present up to a 5-minute presentation accompanied by a short MS PowerPoint presentation. The idea is to engage with the audience with a further brief discussion.
Poster (TPS)
The Poster Presentations will take place onsite in Palma in the poster area. Each abstract presenter will have the opportunity to summarize their main findings and have short presentations of their work to the attendees interested during the Poster Session (TPS).
Notification of acceptance
- Notifications of acceptance of the abstracts will be sent to the presenting author of the abstract by the beginning of September 2025.
Registration and publication of abstracts:
- The presenting author of an abstract must register until 15 September 2025. The presenting author is offered a special extended “early fee”.
Contact: please contact the PAAM 2025 Abstract Team at abstract@eaaci.org for all enquiries about abstracts and/or if you do not receive a confirmation e-mail after submitting an abstract (please do not resubmit the abstract).
Abstract Submission Guidelines and Terms and Conditions will be available soon.